Our Recommendations
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
- Monkeypox: Caring for the skin (2022)
- Landscape of Therapeutics licensed or under development for Mpox (2024)
- Landscape of vaccines licensed or under development for Mpox (2024)
New Publications
- Essential and actionable measures for enhancing country preparedness for Viral Haemorrhagic Fever outbreaks in the WHO African Region (2024)
- Revised National Guidelines on Mpox (2024)
- Considerations for wastewater and environmental surveillance for monkeypox virus: interim guidance, 25 November 2024 (2024)
- Protecting Kids: Mpox Guidelines for Schools (2024)
- Multi-country outbreak of mpox, External situation report #42- 9 November 2024 (2024)
Filter
896
Featured
Recommendations
155
New Publications
238
Language
Document type
No document type
435
Guidelines
123
Training Material
51
Manuals
43
Situation Updates
40
Fact sheets
40
Online Courses
38
Studies & Reports
37
Infographics
28
Strategic & Response Plan
27
Resource Platforms
22
Videos
11
Dashboards/Maps
1
Countries / Regions
Congo, Democratic Republic of
32
Brazil
27
Nigeria
23
Guinea
23
Sierra Leone
21
Africa
21
Liberia
20
Madagascar
20
Latin America and the Carribbean
19
Senegal
18
Burkina Faso
17
Rwanda
16
Global
15
Côte d’Ivoire / Ivory Coast
14
Germany
13
Angola
12
Mozambique
11
Western and Central Europe
11
Russia
11
Mali
11
West and Central Africa
9
India
9
Uganda
8
Indonesia
8
Ghana
7
Syria
7
Ethiopia
7
East and Southern Africa
6
South Africa
6
Somalia
6
Paraguay
5
Portugal
5
Yemen
5
Chad
5
South Sudan
5
Colombia
4
Kenya
4
Togo
4
Burundi
4
Peru
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Argentina
4
Vietnam
4
Sri Lanka
4
China
3
Cameroon
3
Niger
3
Central African Republic
3
Nepal
2
Afghanistan
2
Zimbabwe
2
USA
2
Asia
2
Venezuela
2
Bolivia
2
Bangladesh
2
Serbia
1
Turkey
1
Benin
1
Gambia
1
Iran
1
Kyrgyzstan
1
Philippines
1
Italy
1
Haiti
1
Dominican Republic
1
Guinea-Bissau
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Western Pacific Region
1
Turkmenistan
1
Japan
1
United Kingdom
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Sudan
1
Honduras
1
Zambia
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
143
Key Resources
139
Countries
105
Public Health
60
Capacity Building
49
Pharmacy & Technologies
33
Women & Child Health
4
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
22 September 2024
Flyer German
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.
Du 09 janvier au 08 avril 2024, le Congo a confirmé 19 cas de Mpox dans 04 départements, à savoir : 14 cas dans la Cuvette, 02 cas dans la Likouala, 02 cas dans les Plateaux et 01 cas à Pointe-Noire. Au regard de cette situation, le Gouvernement de la République, via le Ministère de la Santé ...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi...
Situation Report
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
The safety of children is a top concern for parents and school authorities in the current mpox outbreak, as those
under 15 face elevated risks, particularly in the hardesthit Northwestern and Eastern regions of the Democratic Republic of the Congo.
interim guidance, 25 November 2024
The target audience of this document (and the associated online companion tool) includes WHO country offices
in Member States of the African Region; Member States’ ministries of health and their public health emergency
operation centres; relevant external assessment teams; and partners looking...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
